アメーバ症の世界市場レポート 2025年

アメーバ症市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.6％で、11億4,000万米ドルに成長します。予測期間における成長の原動力は、免疫不全集団の有病率の上昇、衛生・ヘルスケアインフラの強化に向けた政府の取り組みの増加、新たな治療法の研究に向けた投資の拡大、寄生虫症対策に向けた保健活動の重点化、効果的な経口薬に対する需要の高まりにあるとみられます。この期間の主な動向としては、併用療法の採用増加、ワクチンの開発、ドラッグデリバリー・システムの発展、製薬研究の進展、新規抗原虫薬の創出などが挙げられます。

寄生虫感染症の罹患率の上昇は、アメーバ症市場の成長を牽引すると予想されます。寄生虫感染症は、原虫、蠕虫、外部寄生虫などの生物によって引き起こされ、宿主の上または宿主の内部に生息し、宿主の犠牲の上に栄養を得ています。旅行者の増加、気候変動、劣悪な衛生環境、薬剤耐性の増加など、さまざまな要因がこれらの感染症の蔓延と持続に寄与しています。腸管出血性大腸菌（Entamoeba histolytica）によって引き起こされるアメーバ症は、腸に侵入して下痢や腹痛などの症状を引き起こし、組織損傷や肝膿瘍などの重篤な合併症を引き起こすことで、寄生虫感染症において重要な役割を果たしています。例えば、英国の政府機関である動植物衛生庁（Animal and Plant Health Agency）は2024年1月、2022年の寄生虫性胃腸炎（PGE）患者数1,071例（うちヘモキナーゼ症190例、線虫症95例）を報告しています。ヘモンクシス症例数は前年を著しく上回りました。その結果、寄生虫感染症の有病率の増加がアメーバ症市場の拡大に拍車をかけています。

劣悪な衛生環境が蔓延していることも、アメーバ症市場の成長に寄与しています。清潔な水への不十分なアクセス、不適切な汚水処理、不衛生な施設を含む劣悪な衛生環境は、感染症の蔓延を促進します。特に発展途上地域では、適切な廃棄物管理の欠如、不十分なインフラ、急速な都市化、清潔な水へのアクセス制限などが、衛生不良の蔓延を促進する主な要因となっています。汚染された水や食物源は、寄生虫であるエンタモエバ・ヒストリチカの蔓延を助長する環境を作り出すため、アメーバ症はこのような状況下で増殖します。例えば、2023年7月、国連水機関は、2022年に20億人が基本的な衛生サービスを利用できず、35億人が安全に管理された衛生設備を利用できていないと報告しました。この広範な問題が、アメーバ症市場におけるソリューションの需要を牽引し続けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アメーバ症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアメーバ症市場：成長率分析
• 世界のアメーバ症市場の実績：規模と成長, 2019-2024
• 世界のアメーバ症市場の予測：規模と成長, 2024-2029, 2034F
• 世界アメーバ症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアメーバ症市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトロニダゾール
• パロモマイシン
• チニダゾール
• 世界のアメーバ症市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• 世界のアメーバ症市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 薬局
• 世界のアメーバ症市場メトロニダゾールの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口メトロニダゾール
• 静脈内メトロニダゾール
• メトロニダゾールとの併用療法
• 世界のアメーバ症市場パロモマイシンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口パロモマイシン
• パロモマイシンと他の薬剤の併用
• 世界のアメーバ症市場チニダゾールの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口チニダゾール
• 重症感染症に対するチニダゾール

第7章 地域別・国別分析

• 世界のアメーバ症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアメーバ症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アメーバ症市場：競合情勢
• アメーバ症市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Eli Lilly and Company
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• Siemens Healthineers AG
• Becton Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• Lupin Limited
• Cepheid Inc.
• Mission Pharmacal Company
• Profounda Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アメーバ症市場2029：新たな機会を提供する国
• アメーバ症市場2029：新たな機会を提供するセグメント
• アメーバ症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Amebiasis is an intestinal infection caused by the parasite *Entamoeba histolytica*, often resulting in symptoms such as diarrhea, abdominal pain, and, in some cases, liver abscesses. This infection is treated with medications such as metronidazole and tinidazole, which work by targeting the parasite in both the gut and tissues.

The primary drugs used to treat amebiasis include metronidazole, paromomycin, and tinidazole. Metronidazole is an antibiotic that eliminates certain bacteria and parasites by disrupting their DNA, making it an effective treatment for amebiasis. The medications can be administered through various routes, including oral and intravenous, and are commonly used in healthcare settings such as hospitals and pharmacies.

The amebiasis market research report is one of a series of new reports from The Business Research Company that provides amebiasis market statistics, including the amebiasis industry global market size, regional shares, competitors with the amebiasis market share, detailed amebiasis market segments, market trends, and opportunities, and any further data you may need to thrive in the amebiasis industry. This amebiasis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The amebiasis market size has grown strongly in recent years. It will grow from $0.82 billion in 2024 to $0.88 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the rising incidence of amoebic infections in tropical regions, inadequate sanitation and hygiene practices in developing countries, increased international travel to endemic areas, greater awareness of the disease, and limited access to clean drinking water in rural areas.

The amebiasis market size is expected to see strong growth in the next few years. It will grow to $1.14 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period is expected to be driven by the rising prevalence of immunocompromised populations, increasing government efforts to enhance sanitation and healthcare infrastructure, growing investments in research for new treatments, a stronger focus on health initiatives to combat parasitic diseases, and the rising demand for effective oral medications. Key trends during this period include the increasing adoption of combination therapies, the development of vaccines, advancements in drug delivery systems, progress in pharmaceutical research, and the creation of novel antiprotozoal drugs.

The rising incidence of parasitic infections is expected to drive the growth of the amebiasis market. Parasitic infections are caused by organisms such as protozoa, helminths, or ectoparasites that live on or inside a host, deriving nutrients at the host's expense. Various factors, including increased travel, climate change, poor sanitation, and growing drug resistance, contribute to the spread and persistence of these infections. Amebiasis, caused by the Entamoeba histolytica parasite, plays a significant role in parasitic infections by invading the intestines and leading to symptoms such as diarrhea, abdominal pain, and severe complications such as tissue damage and liver abscesses. For example, in January 2024, the Animal and Plant Health Agency, a UK-based government agency, reported 1,071 cases of Parasitic Gastroenteritis (PGE) in 2022, including 190 cases of haemonchosis and 95 cases of nematodirosis. The number of haemonchosis cases was notably higher than in the previous year. As a result, the increasing prevalence of parasitic infections is fueling the expansion of the amebiasis market.

The widespread issue of poor sanitation is also contributing to the growth of the amebiasis market. Poor sanitation, which includes inadequate access to clean water, improper sewage disposal, and unhygienic facilities, facilitates the spread of infectious diseases. The lack of proper waste management, insufficient infrastructure, rapid urbanization, and limited access to clean water, especially in developing regions, are key factors driving the prevalence of poor sanitation. Amebiasis thrives in such conditions, as contaminated water and food sources create an environment conducive to the spread of the Entamoeba histolytica parasite. For instance, in July 2023, the United Nations Water agency reported that in 2022, 2 billion people lacked access to basic hygiene services, while 3.5 billion did not have safely managed sanitation. This widespread issue continues to drive the demand for solutions in the amebiasis market.

Leading companies in the amebiasis market are focusing on innovative advancements such as ready-to-use oral liquid metronidazole to enhance patient compliance and treatment effectiveness. This pre-prepared liquid antibiotic formulation is designed to simplify treatment, particularly for individuals who have difficulty swallowing pills. In November 2023, Kesin Pharma Corporation, a US-based pharmaceutical company, received approval from the U.S. Food and Drug Administration for Likmez (metronidazole) oral suspension, 500 mg/5 mL. This marks the first ready-to-use oral liquid formulation of metronidazole. The oral suspension provides a pediatric-friendly alternative, making it easier for children to take the medication with accurate dosing, thereby improving adherence to treatment protocols. Additionally, the liquid formulation offers dosing flexibility, allowing healthcare providers to tailor treatment based on the severity of infections and individual patient needs.

Major players in the amebiasis market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Cepheid Inc., Mission Pharmacal Company, Profounda Inc., and Zydus Lifesciences Limited.

North America was the largest region in the amebiasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in amebiasis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the amebiasis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amebiasis market includes revenues earned by entities by providing services such as medical consultation and treatment management, vaccination and preventive services, pharmaceutical services, and diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The amebiasis market also includes sales of antiprotozoal medications, diagnostic kits, vaccines, and probiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amebiasis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amebiasis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amebiasis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amebiasis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Metronidazole; Paromomycin; Tinidazole
• 2) By Route Of Administration: Oral; Intravenous
• 3) By Application: Hospital; Pharmacy
• Subsegments:
• 1) By Metronidazole: Oral Metronidazole; Intravenous Metronidazole; Combination Therapy with Metronidazole
• 2) By Paromomycin: Oral Paromomycin; Paromomycin in Combination with Other Drugs
• 3) By Tinidazole: Oral Tinidazole; Tinidazole for Severe Infections
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amebiasis Market Characteristics

3. Amebiasis Market Trends And Strategies

4. Amebiasis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Amebiasis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Amebiasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Amebiasis Market Growth Rate Analysis
• 5.4. Global Amebiasis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Amebiasis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Amebiasis Total Addressable Market (TAM)

6. Amebiasis Market Segmentation

• 6.1. Global Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metronidazole
• Paromomycin
• Tinidazole
• 6.2. Global Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• 6.3. Global Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Pharmacy
• 6.4. Global Amebiasis Market, Sub-Segmentation Of Metronidazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Metronidazole
• Intravenous Metronidazole
• Combination Therapy with Metronidazole
• 6.5. Global Amebiasis Market, Sub-Segmentation Of Paromomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Paromomycin
• Paromomycin in Combination with Other Drugs
• 6.6. Global Amebiasis Market, Sub-Segmentation Of Tinidazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tinidazole
• Tinidazole for Severe Infections

7. Amebiasis Market Regional And Country Analysis

• 7.1. Global Amebiasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Amebiasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Amebiasis Market

• 8.1. Asia-Pacific Amebiasis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Amebiasis Market

• 9.1. China Amebiasis Market Overview
• 9.2. China Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Amebiasis Market

• 10.1. India Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Amebiasis Market

• 11.1. Japan Amebiasis Market Overview
• 11.2. Japan Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Amebiasis Market

• 12.1. Australia Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Amebiasis Market

• 13.1. Indonesia Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Amebiasis Market

• 14.1. South Korea Amebiasis Market Overview
• 14.2. South Korea Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Amebiasis Market

• 15.1. Western Europe Amebiasis Market Overview
• 15.2. Western Europe Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Amebiasis Market

• 16.1. UK Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Amebiasis Market

• 17.1. Germany Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Amebiasis Market

• 18.1. France Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Amebiasis Market

• 19.1. Italy Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Amebiasis Market

• 20.1. Spain Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Amebiasis Market

• 21.1. Eastern Europe Amebiasis Market Overview
• 21.2. Eastern Europe Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Amebiasis Market

• 22.1. Russia Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Amebiasis Market

• 23.1. North America Amebiasis Market Overview
• 23.2. North America Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Amebiasis Market

• 24.1. USA Amebiasis Market Overview
• 24.2. USA Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Amebiasis Market

• 25.1. Canada Amebiasis Market Overview
• 25.2. Canada Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Amebiasis Market

• 26.1. South America Amebiasis Market Overview
• 26.2. South America Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Amebiasis Market

• 27.1. Brazil Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Amebiasis Market

• 28.1. Middle East Amebiasis Market Overview
• 28.2. Middle East Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Amebiasis Market

• 29.1. Africa Amebiasis Market Overview
• 29.2. Africa Amebiasis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Amebiasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Amebiasis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Amebiasis Market Competitive Landscape And Company Profiles

• 30.1. Amebiasis Market Competitive Landscape
• 30.2. Amebiasis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Amebiasis Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Novartis AG
• 31.3. F. Hoffmann-La Roche Ltd
• 31.4. Eli Lilly and Company
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Siemens Healthineers AG
• 31.8. Becton Dickinson and Company
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Cipla Limited
• 31.11. Hikma Pharmaceuticals PLC
• 31.12. Lupin Limited
• 31.13. Cepheid Inc.
• 31.14. Mission Pharmacal Company
• 31.15. Profounda Inc.

32. Global Amebiasis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Amebiasis Market

34. Recent Developments In The Amebiasis Market

35. Amebiasis Market High Potential Countries, Segments and Strategies

• 35.1 Amebiasis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Amebiasis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Amebiasis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer